Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hologic Inc. (HOLX:NASDAQ), powered by AI.
Hologic Inc. is currently trading at $76.01. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hologic Inc. on Alpha Lenz.
Hologic Inc.'s P/E ratio is 30.4.
“Hologic Inc. trades at a P/E of 30.4 (premium valuation) with solid ROE of 11.1%.”
Ask for details →Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
“Hologic Inc. trades at a P/E of 30.4 (premium valuation) with solid ROE of 11.1%.”
Ask for details →Hologic Inc. (ticker: HOLX) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 7,063 employees. Market cap is $17.2B.
The current price is $76.01 with a P/E ratio of 30.39x and P/B of 3.41x.
ROE is 11.12% and operating margin is 19.15%. Annual revenue is $4.1B.